Type 1 diabetes mellitus is a disease affecting millions of people worldwide and causing the expenditure of millions of euros every year for health care. One of the most promising therapies derives from the use of an artificial pancreas, based on a control system able to maintain the normoglycaemia in the subject affected by diabetes. A dynamic simulation model of the glucose-insulin system can be useful in several circumstances for diabetes care, including testing of glucose sensors, insulin infusion algorithms, and decision support systems for diabetes. This paper considers the problem of the identification of single individual parameters in detailed dynamic models of glucose homeostasis. Optimal model-based design of experiment techniques are used to design a set of clinical tests that allow the model parameters to be estimated in a statistically sound way, while meeting constraints related to safety of the subject and ease of implementation. The model with the estimated set of parameters represents a specific subject and can thus be used for customized diabetes care solutions. Simulated results demonstrate how such an approach can improve the effectiveness of clinical tests and serve as a tool to devise safer and more efficient clinical protocols, thus providing a contribution to the development of an artificial pancreas.